பெல்ஜியன் குடும்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பெல்ஜியன் குடும்பம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பெல்ஜியன் குடும்பம் Today - Breaking & Trending Today

Vers un nouveau géant européen du chocolat

Vers un nouveau géant européen du chocolat
usinenouvelle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usinenouvelle.com Daily Mail and Mail on Sunday newspapers.

New European , Gratuitementl Abonnement To New , Europe May , Belgian Family , Mondelez Or Even Barry , புதியது ஐரோப்பிய , யூரோப் இருக்கலாம் , பெல்ஜியன் குடும்பம் ,

ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments


ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments
Accelerated clinical development of ExeVir s novel llama-derived antibody therapies for potential treatment and prevention of Covid-19
-
-
Joint unique expertise of two Belgian biotechs to provide global access to innovative therapies for a broad range of coronaviruses, including variants of concern
GHENT, Belgium, July 15, 2021 /PRNewswire/ ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, and Mithra Pharmaceuticals (Euronext Brussels: MITRA) announce a new collaboration to utilize the fill and finish capabilities for ExeVir s innovative therapies at Mithra s integrated R&D and manufacturing platform, Mithra CDMO. ....

Xavier Saelens , Renaat Baes , Exevir Bio , Prnewswire Exevir , Torsten Mummenbrauer , Nico Callewaert , Flanders Agency For Innovation Entrepreneurship , Mithra Pharmaceuticals Euronext Brussels , Mithra Pharmaceuticals , Euronext Brussels , Chief Manufacturing Officer , Vir Bio , V Bio Ventures , Belgian Family , Flanders Agency , மித்ரா மருந்துகள் , தலைமை உற்பத்தி அதிகாரி , வீர் உயிர் , வ் உயிர் முயற்சிகள் , பெல்ஜியன் குடும்பம் ,

ExeVir Announces Close of US$50 million / EUR42 million Series A Financing


ExeVir Announces Close of US$50 million / EUR42 million Series A Financing
- Extends Series A with additional EUR19 million led by Fund+
- Unique llama-derived VHH72-Fc antibody (XVR011) for potential treatment and prevention of Covid-19, ready to start first-in-human trials
- XVR011 expected to be effective against SARS-Cov-2 and importantly its rapidly spreading variants and other Sarbecoviruses to emerge in the future
News provided by
Share this article
Share this article
GHENT, Belgium, March 16, 2021 /PRNewswire/ ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that it has closed its Series A financing raising a total of EUR 42 million / US$50 million. The financing was led by Fund+ with VIB, UCB Ventures, SFPI-FPIM, V-Bio Ventures and new investors SRIW, Noshaq, Vives IUF, SambrInvest, as well as several Belgian family offices. ....

France General , Waals Gewest , Region Flamande , Louvain La Neuve , Bruxelles Capitale , Michel Kazatchkine , Xavier Saelens , Prnewswire Exevir , Erica Whittaker , Caroline Thielen , Van Biervliet , Katja Rosenkranz , Exevir Bio , Torsten Mummenbrauer , Philippe Monteyne , Stef Heylen , Nico Callewaert , Investissement Federale Participatie , Belgian Federal Holding , European Life Sciences , Partner At Fund , Hasselt University , Ghent University , University Of Li , University Fund , Life Sciences ,